Credits: AI Generated
Heart stents have saved countless lives and remain one of the most effective treatments for blocked coronary arteries. By improving blood flow to the heart, they help relieve chest pain and lower the risk of serious events such as heart attacks. Today, stent placement is a routine, minimally invasive procedure performed on millions of patients each year. Yet as more people live longer with stents, an important question is gaining attention: how well do these devices hold up over time inside a constantly moving, living artery?
Stents are widely used to treat blocked or narrowed arteries, particularly in people with severe or advanced coronary artery disease. By restoring blood flow, they help ease chest pain, known as angina, which occurs when the heart muscle does not receive enough oxygen and nutrients because of reduced circulation.
Each year, millions of patients undergo stent procedures, making it one of the most commonly performed minimally invasive treatments worldwide. While stents have transformed heart care, it is still important to understand their limitations, especially as newer and more advanced technologies continue to emerge.
Before looking at how stents behave over time, it helps to understand the environment in which they are placed. We got in touch with Dr. Tamil Selvan Muthusamy, Primary Investigator in the MY-IVL Study of Elixir Medical’s Device and Consultant Cardiologist at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), who told us, that coronary arteries, which supply blood to the heart, are living, flexible structures. They bend, twist, stretch, and move constantly with every heartbeat to manage changing blood flow and pressure.
These arteries travel along the surface of the heart, wrapping around its curves from base to tip, delivering oxygen-rich blood to every heart muscle cell. As the heart contracts and relaxes, the arteries shift side to side, stretch lengthwise, and twist repeatedly. Blood flow within them also changes throughout the heartbeat, moving more slowly during contraction and faster during relaxation. This constant motion creates friction and stress along the artery lining, known as the endothelium.
Under healthy conditions, this stress helps maintain vessel function. However, when blood flow is disrupted, small areas of damage can occur, allowing plaques to form, harden, and eventually block the artery.
A stent is a tiny metal mesh tube mounted on a deflated balloon catheter and guided through the arteries to the site of blockage. Once the balloon is inflated, the stent expands, pushing the plaque aside. The balloon is then removed, leaving the stent in place to keep the artery open, much like internal scaffolding.
Over the past two decades, research has shown that stents can behave like rigid cages inside arteries. Dr. Selvan Muthusamy told us that depending on their length and position, they may restrict the artery’s natural ability to bend, twist, stretch, and pulse with each heartbeat. This stiffness can damage the delicate inner lining of the artery and increase stress on the vessel wall by limiting its natural movement.
When these mechanical changes alter normal blood flow patterns, they can trigger inflammation or excessive tissue growth inside the stent. This process, known as restenosis, is one of the main reasons stents fail over time. Long-term studies suggest that stents have an annual failure rate of around 2 to 3 percent. For patients, this may show up as the return of chest pain and, in some cases, can lead to a heart attack.
As explained by Dr. Selvan Muthusamy, the challenge lies in matching rigid implants with arteries that are meant to move continuously. When this balance is disrupted, long-term complications become more likely.
Healthy habits play a major role in protecting stents and overall heart health. Patients are advised to stop smoking, follow a heart-friendly diet low in salt and unhealthy fats, and stay physically active, such as walking for at least 30 minutes a day.
Dr. Selvan Muthusamy said, “Managing weight, blood sugar, blood pressure, and cholesterol is equally important. Taking prescribed medications consistently, participating in cardiac rehabilitation, and attending regular follow-up appointments all help reduce strain on the arteries and lower the risk of complications.”
In recent years, newer technologies have also been developed to address some of the mechanical drawbacks of traditional stents. One such innovation is the bioadaptor implant. Unlike conventional stents that remain permanently fixed, the bioadaptor is designed to change over time. After about six months of healing, it unlocks within the vessel wall and becomes a dynamic scaffold. This allows the artery to regain flexibility, stretch, and natural pulsation. Studies have shown improved blood flow, healthier artery lining, and more than 50 percent better long-term outcomes compared to standard stents.
The most common cause of stent failure is restenosis, where tissue growth gradually narrows the artery again. Patients should pay close attention to symptoms such as chest pain or pressure, shortness of breath, unusual fatigue, a rapid heartbeat, nausea, sweating, or swelling in the legs. These signs may become more noticeable during physical activity.
Seeking medical help promptly when these symptoms appear is critical. Early detection can prevent more serious complications, including heart attacks, and allow doctors to intervene before the problem becomes life-threatening.
Credit: Canva
An international team of researchers has developed an artificial intelligence (AI)-based tool that can significantly improve care for glaucoma -- a leading cause of irreversible blindness worldwide, according to a study published in The Lancet Primary Care journal today.
Researchers led by those from the University of Lisbon in Portugal found that the AI-based screening tool halved the number of unnecessary referrals for glaucoma.
The study, released during the Glaucoma Awareness Week, also showed an accuracy level at par with human eye doctors.
"The high accuracy at excluding people without glaucoma is especially important, as false alarms can lead to unnecessary hospital visits, patient anxiety, and added strain on healthcare services," the researchers said.
According to the researchers, AI-based screening could:
The study was carried out at a single screening center in Lisbon, Portugal, in 2023.
The experts screened 671 adults aged 55-65 for glaucoma via the AI tool, analyzing images of the eyes. The images were then independently graded by six glaucoma experts.
The AI-tool:
While modelling studies suggest that screening could substantially reduce glaucoma-related visual impairment and blindness, barriers include the need for specialised diagnostic equipment and trained personnel, particularly in low- and middle-income countries, and the intrinsically low positive predictive value of screening tests.
In such a scenario, the new study showed that "AI may provide a more viable option than population-wide screening", which may seem impractical.
Glaucoma is a chronic disease that affects an estimated 80 million individuals globally, according to the World Glaucoma Association.
It is a progressive, degenerative disorder of the optic nerve that produces characteristic visual field damage.
The disease stems from a long asymptomatic phase, resulting in substantial underdiagnosis and delayed treatment.
Even in high-income countries, up to 50 percent of individuals with glaucoma remain undiagnosed, frequently presenting moderate to advanced disease at first detection.
By the year 2040, it is estimated that there will be 22 million individuals worldwide who are blind from glaucoma.
When to see a doctor for glaucoma:
Credits: Canva
In adults, long periods of sleep deprivation has been linked to problems such as weakened immunity, weight gain, depression, and an increased risk of dementia. However, scientists are now paying closer attention to how sleep affects the brain much earlier in life.
However, a new University of North Carolina School of Medicine study suggests that disrupted sleep during early childhood may interfere with key stages of brain development and asl well as increase the risk of developing autism.
Sleep plays a crucial role in helping these synapses form and strengthen. During sleep, the brain organizes and stabilizes these neural connections, shaping the foundation for future brain function. If sleep is repeatedly disrupted during this delicate stage of development, the process may be affected.
Frequent waking or sleep disturbances could interfere with how these neural connections are formed, potentially influencing behavior and cognitive abilities later in life.
“The unique effects of sleep loss during development are largely unexplored,” Diering said. “Our data show that babies and children are more vulnerable to the negative effects of sleep disruption. We also found that sleep loss during this crucial period of time can negatively interact with underlying genetic risk for autism spectrum disorder.”
Sleep problems are already known to be common in people with autism. In fact, sleep disruption has been reported in more than 80 percent of individuals with autism spectrum disorder. However, researchers have long debated whether these sleep issues are a cause of the disorder or a consequence of it. Understanding how sleep interacts with brain development could help scientists detect autism earlier and potentially develop new treatment strategies.
In earlier work conducted in 2022, researchers examined how sleep disruption during early life might interact with genetic factors linked to autism. Using mouse models, they disrupted sleep during the third week of life, a developmental stage roughly comparable to ages one to two in humans.
The study found that sleep disruption during this period produced long lasting behavioral changes. Male mice that were genetically vulnerable to autism showed deficits in social behavior later in life. These results suggested that sleep disruption during critical stages of development may interact with genetic risk factors in ways that shape long term behavior.
To investigate further, researchers studied how developing and adult mice respond differently to sleep deprivation.
Using specially designed housing systems equipped with sensitive sensors, scientists tracked the animals’ breathing and movement. This allowed them to determine when the mice were awake and when they were asleep.
The researchers observed that adult mice were able to compensate for lost sleep. After experiencing sleep deprivation, the adults increased their sleep later during their normal active period. This process, known as sleep rebound, allowed them to recover some of the lost rest.
Younger mice behaved very differently. They showed no sleep rebound at all, meaning they did not compensate for the sleep they had lost. This finding suggests that younger brains may be far more vulnerable to the effects of sleep disruption.
The consequences were also visible in cognitive performance. Sleep deprived young mice performed poorly on learning and memory tasks, while adult mice were significantly more resilient after losing sleep.
The results showed that sleep deprivation in young mice significantly altered the formation of synapses. These changes were not seen in adult mice. “This now provides one of the largest and most comprehensive datasets to examine the molecular effects of sleep loss across the lifespan,” Diering said.
“Development is not something that one can go back and do again,” Diering said. “Sleep is important for the entire life and especially during development. Understanding what we know now will place greater emphasis on understanding sleep issues in ASD and could lead to an important therapeutic avenue to treat ASD and other developmental conditions.”
The findings highlight an important message for parents and caregivers. During early childhood, healthy sleep patterns may play a critical role in shaping the brain for years to come.
Credits: Canva
Using amphetamines, cocaine and cannabis can significantly increase your risk of having a brain stroke particularly among younger adults, according to a new University of Cambridge analysis
The findings highlight how recreational drug use may contribute to a preventable health risk, especially among people under the age of 55.
Megan Ritson, a stroke genetics researcher at the University of Cambridge and lead author said the results provide strong evidence linking certain drugs to stroke risk.
“These findings provide compelling evidence that drugs like cocaine, amphetamines, and cannabis are causal risk factors for stroke,” Ritson noted.
A stroke occurs when blood flow to part of the brain is interrupted. This can happen when a blood vessel becomes blocked by a clot, known as an ischemic stroke, or when a blood vessel bursts and causes bleeding in the brain, known as a hemorrhagic stroke. Both types can lead to serious brain damage and can be life threatening.
When researchers combined data from eight previous studies, they found that recreational amphetamine use was associated with more than double the risk of stroke across all adult age groups. For individuals under the age of 55, the increase was even greater. In this group, amphetamine use was linked to nearly triple the risk of stroke compared with people who do not use the drug.
Across all age groups, the analysis found that amphetamine use increased the risk of ischemic stroke by 137 percent and hemorrhagic stroke by 183 percent. These figures reflect relative risk, meaning the probability of stroke is higher among users compared with non users.
The analysis showed that cocaine use nearly doubled the risk of stroke of any kind and more than doubled the risk of hemorrhagic stroke. Additional genetic investigations were conducted alongside the main analysis to better understand whether the relationship might be causal rather than simply linked to other lifestyle factors.
Eric Harshfield, a genetic epidemiologist at the University of Cambridge, said the findings suggest the drugs themselves may play a direct role. “Our analysis suggests that it is these drugs themselves that increase the risk of stroke, not just other lifestyle factors among users,” Harshfield said.
Among people under the age of 55, cannabis use was linked to a 14 percent increase in stroke risk. Although the increase is lower than that associated with stimulant drugs, researchers say it remains important because cannabis is widely used.
The researchers also note that many of the studies included in the analysis relied on participants reporting their own drug use. Because of this, other lifestyle factors could potentially influence the results. Further research will be needed to better understand the biological mechanisms involved and how different patterns of drug use may affect stroke risk. Still, scientists say the evidence now available provides an important foundation for future public health strategies.
“These findings give us stronger evidence to guide future research and public health strategies,” Ritson said.
© 2024 Bennett, Coleman & Company Limited